Zobrazeno 1 - 10
of 124
pro vyhledávání: '"S Gobaille"'
Autor:
Nikolaus Seiler, Christine Grauffel, B. Knödgen, Paula M. Moran, Shakir Sarhan, M van den Buuse, S. Gobaille, J. Elands
Publikováno v:
Pharmacology Biochemistry and Behavior. 50:181-189
Acute and chronic administration of vigabatrin, a selective inactivator of GABA-T, suppresses haloperidol-induced dyskinesias at low doses without preventing the enhancement of striatal dopamine D2 receptor density or the development of vacuous chewi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::149fcec81ac61eed9f2af2205092178c
https://doi.org/10.1016/0091-3057(94)00282-n
https://doi.org/10.1016/0091-3057(94)00282-n
Publikováno v:
Gamma-Hydroxybutyrate: Molecular, functional and clinical aspects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12c4bdf760839f71b2b486d7b61a496d
https://doi.org/10.4324/9780203300992_chapter_14
https://doi.org/10.4324/9780203300992_chapter_14
Publikováno v:
The European journal of neuroscience. 14(10)
The neuropeptide C-type natriuretic peptide (CNP) is the primary biologically active natriuretic peptide in brain. Using in situ hybridization, the present report demonstrates that CNP regulates egr-1, c-fos and junB immediate early gene expression i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3a994cea8f3f0bfeaf2082dbd2bbf8f1
https://pubmed.ncbi.nlm.nih.gov/11860464
https://pubmed.ncbi.nlm.nih.gov/11860464
Autor:
G, Hédou, S, Chasserot-Golaz, V, Kemmel, S, Gobaille, G, Roussel, J C, Artault, C, Andriamampandry, D, Aunis, M, Maitre
Publikováno v:
The Journal of comparative neurology. 426(4)
gamma-Hydroxybutyrate (GHB) is an endogenous metabolite of gamma-aminobutyric acid (GABA), which is synthesized in the neuronal compartment of the central nervous system. This substance possesses several properties that support its role as a neurotra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::12b5491d027000e70323864aba864b7c
https://pubmed.ncbi.nlm.nih.gov/11027398
https://pubmed.ncbi.nlm.nih.gov/11027398
Autor:
V, Hechler, P, Peter, S, Gobaille, J J, Bourguignon, M, Schmitt, J D, Ehrhardt, J, Mark, M, Maitre
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 264(3)
The action of agonists or antagonists at the gamma-hydroxybutyrate (GHB) receptor represents a possibility to modulate dopaminergic activities in brain. In the present study, GHB and six structural analogs were tested for their ability to displace [3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::46418971d78f056e13c42712d34c1e8d
https://pubmed.ncbi.nlm.nih.gov/8095552
https://pubmed.ncbi.nlm.nih.gov/8095552
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 255(2)
Administration of gamma-hydroxybutyrate (GHB) to animals induces electroencephalographic and behavioral changes that resemble petit-mal seizures. Furthermore, these GHB-induced electroencephalogram-behavioral changes can be blocked by anticonvulsant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dbeedc6e8fbfa1a70a1f806cbb2627b7
https://pubmed.ncbi.nlm.nih.gov/2173754
https://pubmed.ncbi.nlm.nih.gov/2173754
Publikováno v:
Neuropeptides. 8:213-219
Bilateral Olfactory Bulb Removal (OBR) induced both complex behavioral alterations and a decrease of many neurotransmitter levels. We studied brain levels of the pro-enkephalin related peptides 45 days after OBR. Opioid levels were studied using thre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e85d006691546aa845adbbd1db3db793
https://doi.org/10.1016/0143-4179(86)90049-1
https://doi.org/10.1016/0143-4179(86)90049-1
Publikováno v:
The Journal of Pharmacology and Experimental Therapeutics; July 1999, Vol. 290 Issue: 1 p303-9, 7p
Publikováno v:
Comptes rendus des seances de la Societe de biologie et de ses filiales. 175(1)
The hypothesis that the brain GABA level increase which is induced by a sodium dipropyl acetate treatment arises either through inhibition of succinic semialdehyde dehydrogenase (SSADH), or through inhibition of GABA transaminase by succinic semialde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::049dfd385e560ac7bc9fb17cb28b677b
https://pubmed.ncbi.nlm.nih.gov/6452931
https://pubmed.ncbi.nlm.nih.gov/6452931
Autor:
P, Mandel, R C, Gupta, J J, Bourguignon, C G, Wermuth, V, Molina, S, Gobaille, L, Ciesielski, S, Simler
Publikováno v:
Progress in clinical and biological research. 179
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::69d595aeddd85618577e7f5d9ad8caaf
https://pubmed.ncbi.nlm.nih.gov/2865743
https://pubmed.ncbi.nlm.nih.gov/2865743